Editorial Policy

MagnaMetabolic is an educational resource. This policy describes how we develop, review, and update content.

Written by MagnaMetabolic Editorial Team Medically reviewed by Ariel Ortiz, MD — Bariatric & Metabolic Surgery Last reviewed: June 7, 2026

Mission

Provide accessible, evidence-based education about metabolic disease — obesity, insulin resistance, type 2 diabetes, MASLD/MASH, hypertension, dyslipidemia, sleep apnea, and related conditions — to support informed conversations with qualified clinicians.

Content development

Articles are written by the MagnaMetabolic Editorial Team and reviewed by a member of the Medical Review Board with relevant clinical expertise. Drafts undergo a sources check, plain-language editing, and an accuracy review before publication.

Sourcing standards

We prioritize current clinical practice guidelines (ADA, AACE, AHA/ACC, AASLD, Endocrine Society, IFSO), randomized controlled trials, systematic reviews, and authoritative public-health sources (NIH, NIDDK, WHO). When evidence is evolving or consensus is incomplete, we say so.

What we avoid

Claims of cure, reversal, or guarantees of outcome for any therapy.
Treatment recommendations for individual patients (this requires a clinician).
Promotional language framed as medical fact.
Personal-attribute targeting language in advertising (e.g., "you have diabetes — try this").

Updates and corrections

Articles display a "Last reviewed" date. Substantive updates are noted in-line. To report a possible error, contact editorial@magnametabolic.com.

Independence

Educational content is editorially independent of advertising and partner relationships. Where a procedure offered within the OCC & Ariel Center network is discussed, we identify it as such.